MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.400
+0.080 (6.06%)
Jun 18, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $85.12 million as of June 18, 2026. Its market cap has increased by 59.58% in one year.
Market Cap
85.12M
Enterprise Value
50.71M
1-Year Change
59.58%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $85.12M, an increase of 66.58%. That is a compound annual growth rate of 14.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 85.12M | 45.39% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Champions Oncology | 87.76M |
| OS Therapies | 85.96M |
| ImmuCell | 85.85M |
| Aardvark Therapeutics | 85.74M |
| Biomea Fusion | 85.31M |
| Rein Therapeutics | 85.20M |
| Adicet Bio | 85.06M |
| Rallybio | 84.48M |